Test twice? Antigen tests reach peak sensitivity 4 days in, study finds
By
Alicia Lasek (f3)
May 03, 2022
It may be best to repeat an early COVID-19 antigen test a day or two later when symptomatic individuals receive negative results, investigators say.
Post-COVID complaints continue to affect recovered healthcare workers, study finds
By
Alicia Lasek (f3)
Jul 21, 2022
Pulmonary tests may be useful in the decision to return to work, and should be received regularly after workers with lingering issues are back on the job, investigators say.
Nursing home COVID-19 infections quadruple as booster rate slows
By
Alicia Lasek (f3)
Jun 21, 2022
An AARP analysis shows a sharp uptick in infections between mid-April and mid-May, while residents’ booster shots have slowed to a trickle.
COVID-19 again the third leading cause of death, while elderly deaths decrease
By
Alicia Lasek (f3)
Apr 25, 2022
U.S. mortality from COVID-19 increased overall in 2021, but there has been a decline in deaths among the elderly and other shifts in who is severely affected by the disease, the CDC reports.
COVID-19 patients face higher risk of neurodegenerative disorders: study
By
Alicia Lasek (f3)
Jul 01, 2022
People who test positive for COVID-19 are at an increased risk of Alzheimer’s disease, Parkinson’s disease and ischemic stroke, a large new study finds.
CDC: Turn to Paxlovid to treat COVID-19, not steroids or antibiotics
By
Alicia Lasek (f3)
Apr 26, 2022
The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.
CDC: Deaths from antibiotic-resistant bacteria jumped 15% in 2020
By
Alicia Lasek (f3)
Jul 13, 2022
The COVID-19 pandemic has “pushed back years of progress” in combating antimicrobial resistance in the United States, the CDC reports.
White House urges greater use of Paxlovid as supply increases
By
Alicia Lasek (f3)
Apr 28, 2022
Health officials are encouraging physicians to more frequently consider prescribing the oral antiviral now that it is no longer in short supply.
Paxlovid keeping hospitalizations, deaths low as COVID-19 infections rise, White House official says
By
Alicia Lasek (f3)
May 19, 2022
Clinicians are writing 20,000 prescriptions for Paxlovid each day, helping to keep severe outcomes in check, the COVID-19 Response Coordinator said Wednesday.
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.